Exploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In Vivo-Reference-Cited by-同舟云学术

Exploitation of Synthetic mRNA To Drive Immune Effector Cell Recruitment and Functional Reprogramming In Vivo

Published:2018-12-12 Issue:2 Volume:202 Page:608-617
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Xu Yitian^ORCID,Huang Lu^ORCID,Kirschman Jonathan L.,Vanover Daryll A.^ORCID,Tiwari Pooja M.^ORCID,Santangelo Philip J.,Shen Xiling^ORCID,Russell David G.^ORCID

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference56 articles.

1. mRNA as a versatile tool for exogenous protein expression.;Kuhn;Curr. Gene Ther.,2012

2. mRNA-based therapeutics — developing a new class of drugs

3. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice

4. Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L

5. N1-methylpseudouridine-incorporated mRNA outperforms pseudouridine-incorporated mRNA by providing enhanced protein expression and reduced immunogenicity in mammalian cell lines and mice

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Reprogramming and Differentiation Utilizing Messenger RNA for Regenerative Medicine;Journal of Developmental Biology;2023-12-20

2. Chemical modification of uridine modulates mRNA-mediated proinflammatory and antiviral response in primary human macrophages;Molecular Therapy - Nucleic Acids;2022-03

3. Leveraging immune memory against measles virus as an antitumor strategy in a preclinical model of aggressive squamous cell carcinoma;Journal for ImmunoTherapy of Cancer;2021-10

4. Viromers as carriers for mRNA-mediated expression of therapeutic molecules under inflammatory conditions;Scientific Reports;2020-09-15

5. Nanomedicine-Based Approaches for mRNA Delivery;Molecular Pharmaceutics;2020-08-26